EGFR EXON 20 INSERTION MUTATION
Clinical trials for EGFR EXON 20 INSERTION MUTATION explained in plain language.
Never miss a new study
Get alerted when new EGFR EXON 20 INSERTION MUTATION trials appear
Sign up with your email to follow new studies for EGFR EXON 20 INSERTION MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy for lung cancer under Real-World watch
Knowledge-focused Recruiting nowThis observational study follows 100 adults with metastatic non-small cell lung cancer who have certain EGFR gene mutations and are receiving amivantamab plus platinum-based chemotherapy through an early access program. Researchers will collect medical data to see how long the tr…
Matched conditions: EGFR EXON 20 INSERTION MUTATION
Sponsor: GFPC Investigation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Scientists probe resistance to targeted lung cancer drug
Knowledge-focused Recruiting nowThis study looks at why amivantamab, a drug for advanced non-small cell lung cancer with a specific EGFR mutation, stops working over time. Researchers will collect blood and tumor samples from 30 patients when their disease gets worse. The goal is to find genetic changes that ca…
Matched conditions: EGFR EXON 20 INSERTION MUTATION
Phase: NA • Sponsor: Groupe Francais De Pneumo-Cancerologie • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC